RESILIENCE DIAGNOSTIC PLATFORM LTD

Executive Summary

Resilience Diagnostic Platform Ltd is a dormant company with no trading history or financial activity beyond nominal share capital. The absence of assets, revenue, or cash flow precludes any credit facility approval at this time. Ongoing monitoring should focus on the company’s transition to active trading and financial disclosures before reconsidering credit support.

RESILIENCE DIAGNOSTIC PLATFORM LTD - Analysis Report

Company Number: SC686897

Analysis Date: 2025-07-29 16:53 UTC

1. Credit Opinion: DECLINE
   Resilience Diagnostic Platform Ltd is currently a dormant company with minimal financial activity since incorporation in 2021. It has consistently reported net assets and shareholders' funds of £1, reflecting only the nominal share capital. There is no evidence of trading, revenue generation, or operational cash flows. Consequently, there is no financial basis to assess its ability to service debt or meet credit obligations.

2. Financial Strength:
   The balance sheet shows an entirely minimal financial position with net assets of £1, representing the single issued share of £1. No fixed or current assets, liabilities, or reserves are reported. This indicates the company holds no tangible or intangible assets and no capital beyond the nominal share capital. The absence of financial activity suggests no capitalization or investment in business operations.

3. Cash Flow Assessment:
   As a dormant entity, there are no reported cash flows, working capital, or liquidity metrics available. The company does not generate income or incur expenses. Therefore, it cannot sustain any credit facility or meet repayment commitments.

4. Monitoring Points:

• Monitor for any change from dormant to active trading status with associated filing of trading accounts.
• Watch for increases in net assets, turnover, or signs of operational activity.
• Verify director’s intentions and business plans if credit is requested in the future.
• Confirm timely filing of accounts and confirmation statements to ensure regulatory compliance.